J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study

Investing.com Gold reports: J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study. Full body text was unavailable at ingest time, so this brief is based on headline context.